NEW YORK, Jan 17 (Reuters) - New Jersey's attorney general said on Thursday she has subpoenaed Amgen Inc regarding allegations that the biotechnology company promoted its rheumatoid arthritis and ...
Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a biosimilar product in the United States to compete with Amgen's blockbuster Enbrel ...
The biotechnology industry's hottest new product in a decade just got hotter. Enbrel, an injectable drug that illustrates the potential of new treatments based on genetic knowledge, has been approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results